Skip to main content
SpringerLink
Log in

Congenital Non-Degenerative Retinal Diseases

  • Chapter
  • First Online:
Handbook of Clinical Electrophysiology of Vision

  • 845 Accesses

Abstract

Electrophysiologic tests are used widely in the objective functional examinations in different retinal diseases for several reasons as follows: (1) Differentiation of those diseases with similar symptoms and results from other examinations. Electrophysiologic tests have different characteristics in different diseases. (2) For quantitatively monitoring of the treatment effect or the development of disease. (3) Electrophysiologic tests are more sensitive than other examinations in some diseases. (4) For those patients (e.g., pediatric patients, elderly patients, psychiatric patients, or the patients that intend to bias the results of examinations) who are uncooperative in performing some examinations (e.g., perimetry and visual acuity test). This chapter summarizes the application of electroretinogram and/or visual evoked potential in patients with congenital stationary night blindness, Oguchi disease, fundus albipunctatus, achromatopsia, blue cone monochromatism, and mutations of paired box 6 gene.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dryja TP, et al. Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet. 1996;13(3):358–60.

    CAS  PubMed  Google Scholar 

  2. Riazuddin SA, et al. A mutation in SLC24A1 implicated in autosomal-recessive congenital stationary night blindness. Am J Hum Genet. 2010;87(4):523–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Pusch CM, et al. The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet. 2000;26(3):324–7.

    CAS  PubMed  Google Scholar 

  4. Bech-Hansen NT, et al. Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet. 2000;26(3):319–23.

    CAS  PubMed  Google Scholar 

  5. Zeitz C, et al. Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram. Invest Ophthalmol Vis Sci. 2005;46(11):4328–35.

    PubMed  Google Scholar 

  6. Dryja TP, et al. Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6. Proc Natl Acad Sci U S A. 2005;102(13):4884–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Audo I, et al. TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet. 2009;85(5):720–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Li Z, et al. Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Am J Hum Genet. 2009;85(5):711–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. van Genderen MM, et al. Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. Am J Hum Genet. 2009;85(5):730–6.

    PubMed  PubMed Central  Google Scholar 

  10. Audo I, et al. Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet. 2012;90(2):321–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Peachey NS, et al. GPR179 is required for depolarizing bipolar cell function and is mutated in autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet. 2012;90(2):331–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Vincent A, et al. Biallelic mutations in GNB3 cause a unique form of autosomal-recessive congenital stationary night blindness. Am J Hum Genet. 2016;98(5):1011–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Zeitz C, et al. Whole-exome sequencing identifies LRIT3 mutations as a cause of autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet. 2013;92(1):67–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Glass IA, et al. Genetic mapping of a cone and rod dysfunction (Aland Island eye disease) to the proximal short arm of the human X chromosome. J Med Genet. 1993;30(12):1044–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Bech-Hansen NT, et al. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet. 1998;19(3):264–7.

    CAS  PubMed  Google Scholar 

  16. Strom TM, et al. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet. 1998;19(3):260–3.

    CAS  PubMed  Google Scholar 

  17. Zeitz C, et al. Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet. 2006;79(4):657–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Littink KW, et al. A novel homozygous nonsense mutation in CABP4 causes congenital cone-rod synaptic disorder. Invest Ophthalmol Vis Sci. 2009;50(5):2344–50.

    PubMed  Google Scholar 

  19. Bijveld MM, et al. Genotype and phenotype of 101 dutch patients with congenital stationary night blindness. Ophthalmology. 2013;120(10):2072–81.

    PubMed  Google Scholar 

  20. Kurata K, Hosono K, Hotta Y. Long-term clinical course in a patient with complete congenital stationary night blindness. Case Rep Ophthalmol. 2017;8(1):237–44.

    PubMed  PubMed Central  Google Scholar 

  21. Miyake Y, et al. Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol. 1986;104(7):1013–20.

    CAS  PubMed  Google Scholar 

  22. Hayashi T, et al. A novel homozygous GRK1 mutation (P391H) in 2 siblings with Oguchi disease with markedly reduced cone responses. Ophthalmology. 2007;114(1):134–41.

    PubMed  Google Scholar 

  23. Yamamoto S, et al. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet. 1997;15(2):175–8.

    CAS  PubMed  Google Scholar 

  24. Mucciolo DP, et al. A novel GRK1 mutation in an Italian patient with Oguchi disease. Ophthalmic Genet. 2018;39(1):137–8.

    PubMed  Google Scholar 

  25. Fuchs S, et al. A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet. 1995;10(3):360–2.

    CAS  PubMed  Google Scholar 

  26. Maw M, et al. Two Indian siblings with Oguchi disease are homozygous for an arrestin mutation encoding premature termination. Hum Mutat. 1998;11(Suppl 1):S317–9.

    Google Scholar 

  27. Maw MA, et al. Oguchi disease: suggestion of linkage to markers on chromosome 2q. J Med Genet. 1995;32(5):396–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Nakazawa M, et al. Oguchi disease: phenotypic characteristics of patients with the frequent 1147delA mutation in the arrestin gene. Retina. 1997;17(1):17–22.

    CAS  PubMed  Google Scholar 

  29. Cideciyan AV, et al. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc Natl Acad Sci U S A. 1998;95(1):328–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Huang L, et al. A Chinese family with Oguchi’s disease due to compound heterozygosity including a novel deletion in the arrestin gene. Mol Vis. 2012;18:528–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Sergouniotis PI, et al. Mizuo-Nakamura phenomenon in Oguchi disease due to a homozygous nonsense mutation in the SAG gene. Eye (Lond). 2011;25(8):1098–101.

    CAS  Google Scholar 

  32. Yuan A, Nusinowitz S, Sarraf D. Mizuo--Nakamura phenomenon with a negative waveform ERG. Br J Ophthalmol. 2011;95(1):147–8. 156

    CAS  PubMed  Google Scholar 

  33. Miyake Y, et al. Electrophysiological findings in patients with Oguchi’s disease. Jpn J Ophthalmol. 1996;40(4):511–9.

    CAS  PubMed  Google Scholar 

  34. Fujinami K, et al. Oguchi disease with unusual findings associated with a heterozygous mutation in the SAG gene. Arch Ophthalmol. 2011;129(10):1375–6.

    PubMed  Google Scholar 

  35. Hayashi T, et al. Macular dysfunction in Oguchi disease with the frequent mutation 1147delA in the SAG gene. Ophthalmic Res. 2011;46(4):175–80.

    CAS  PubMed  Google Scholar 

  36. Schatz P, et al. Fundus albipunctatus associated with compound heterozygous mutations in RPE65. Ophthalmology. 2011;118(5):888–94.

    PubMed  Google Scholar 

  37. Liu X, et al. RDH5 retinopathy (fundus albipunctatus) with preserved rod function. Retina. 2015;35(3):582–9.

    CAS  PubMed  Google Scholar 

  38. Yamamoto H, et al. Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet. 1999;22(2):188–91.

    CAS  PubMed  Google Scholar 

  39. Margolis S, Siegel IM, Ripps H. Variable expressivity in fundus albipunctatus. Ophthalmology. 1987;94(11):1416–22.

    CAS  PubMed  Google Scholar 

  40. Iannaccone A, et al. Fundus albipunctatus in a 6-year old girl due to compound heterozygous mutations in the RDH5 gene. Doc Ophthalmol. 2007;115(2):111–6.

    PubMed  Google Scholar 

  41. Hajali M, et al. Diagnosis in a patient with fundus albipunctatus and atypical fundus changes. Doc Ophthalmol. 2009;118(3):233–8.

    PubMed  Google Scholar 

  42. Ruther K, et al. Clinical and genetic findings in a patient with fundus albipunctatus. Ophthalmologe. 2004;101(2):177–85.

    CAS  PubMed  Google Scholar 

  43. Hotta K, et al. Macular dystrophy in a Japanese family with fundus albipunctatus. Am J Ophthalmol. 2003;135(6):917–9.

    PubMed  Google Scholar 

  44. Nakamura M, Miyake Y. Macular dystrophy in a 9-year-old boy with fundus albipunctatus. Am J Ophthalmol. 2002;133(2):278–80.

    PubMed  Google Scholar 

  45. Miyazaki K, et al. [A case of fundus albipunctatus with a retinol dehydrogenase 5 gene mutation in a child]. Nippon Ganka Gakkai Zasshi. 2001;105(8):530–4.

    Google Scholar 

  46. Naz S, et al. Mutations in RLBP1 associated with fundus albipunctatus in consanguineous Pakistani families. Br J Ophthalmol. 2011;95(7):1019–24.

    PubMed  PubMed Central  Google Scholar 

  47. Dryja TP. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2000;130(5):547–63.

    CAS  PubMed  Google Scholar 

  48. Skorczyk-Werner A, et al. Fundus albipunctatus: review of the literature and report of a novel RDH5 gene mutation affecting the invariant tyrosine (p.Tyr175Phe). J Appl Genet. 2015;56(3):317–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Wang NK, et al. Multimodal fundus imaging in fundus albipunctatus with RDH5 mutation: a newly identified compound heterozygous mutation and review of the literature. Doc Ophthalmol. 2012;125(1):51–62.

    PubMed  Google Scholar 

  50. Pras E, et al. Fundus albipunctatus: novel mutations and phenotypic description of Israeli patients. Mol Vis. 2012;18:1712–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Sergouniotis PI, et al. Phenotypic variability in RDH5 retinopathy (Fundus Albipunctatus). Ophthalmology. 2011;118(8):1661–70.

    PubMed  Google Scholar 

  52. Niwa Y, et al. Cone and rod dysfunction in fundus albipunctatus with RDH5 mutation: an electrophysiological study. Invest Ophthalmol Vis Sci. 2005;46(4):1480–5.

    PubMed  Google Scholar 

  53. Pascual-Camps I, et al. Diagnosis and treatment options for achromatopsia: a review of the literature. J Pediatr Ophthalmol Strabismus. 2018;55(2):85–92.

    PubMed  Google Scholar 

  54. Zobor D, Zobor G, Kohl S. Achromatopsia: on the doorstep of a possible therapy. Ophthalmic Res. 2015;54(2):103–8.

    PubMed  Google Scholar 

  55. Luo X, et al. Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials. PLoS One. 2015;10(4):e0125700.

    PubMed  PubMed Central  Google Scholar 

  56. Gardner JC, et al. Blue cone monochromacy: causative mutations and associated phenotypes. Mol Vis. 2009;15:876–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Sumaroka A, et al. Blue cone monochromacy caused by the C203R missense mutation or large deletion mutations. Invest Ophthalmol Vis Sci. 2018;59(15):5762–72.

    CAS  PubMed  Google Scholar 

  58. Gardner JC, et al. Three different cone opsin gene array mutational mechanisms with genotype-phenotype correlation and functional investigation of cone opsin variants. Hum Mutat. 2014;35(11):1354–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Orosz O, et al. Myopia and late-onset progressive cone dystrophy associate to LVAVA/MVAVA exon 3 interchange haplotypes of opsin genes on chromosome X. Invest Ophthalmol Vis Sci. 2017;58(3):1834–42.

    CAS  PubMed  Google Scholar 

  60. Skalak C, et al. A simple, clinician-friendly perimetric approach to the differential diagnosis between blue cone monochromacy (BCM) and achromatopsia (ACHM): a pilot study. Invest Ophthalmol Vis Sci. 2018;59(9):4045.

    Google Scholar 

  61. Walther C, Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNS. Development. 1991;113(4):1435–49.

    CAS  PubMed  Google Scholar 

  62. Hingorani M, Hanson I, van Heyningen V. Aniridia. Eur J Hum Genet. 2012;20(10):1011–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Guo H, et al. A large novel deletion downstream of PAX6 gene in a Chinese family with ocular coloboma. PLoS One. 2013;8(12):e83073.

    PubMed  PubMed Central  Google Scholar 

  64. Jia X, et al. A novel mutation of PAX6 in Chinese patients with new clinical features of Peters’ anomaly. Mol Vis. 2010;16:676–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Hood MP, et al. Abnormal cone ERGs in a family with congenital nystagmus and photophobia harboring a p.X423Lfs mutation in the PAX6 gene. Doc Ophthalmol. 2015;130(2):157–64.

    PubMed  Google Scholar 

  66. Yokoi T, et al. Genotype-phenotype correlation of PAX6 gene mutations in aniridia. Hum Genome Var. 2016;3:15052.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Tremblay F, et al. Effects of PAX6 mutations on retinal function: an electroretinographic study. Am J Ophthalmol. 1998;126(2):211–8.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Retinal Degenerations and Ophthalmic Genetic Diseases, Duke University School of Medicine, Duke Eye Center, Department of Ophthalmology, Durham, NC, USA

    Wajiha Jurdi Kheir, Roberto Gattegna, Alessandro Racioppi, Alfonso Senatore & Alessandro Iannaccone

  2. Retina Service, Israelitic Hospital, Rome, Italy

    Roberto Gattegna

  3. Department of Ophthalmology, University Hospitals Eye Institute, Cleveland, OH, USA

    Minzhong Yu

  4. University of North Carolina, Chapel Hill, NC, USA

    Alessandro Racioppi

  5. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA

    Donnell Creel

Authors
  1. Wajiha Jurdi Kheir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto Gattegna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Minzhong Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandro Racioppi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alfonso Senatore
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Donnell Creel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alessandro Iannaccone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minzhong Yu .

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, University Hospitals Eye Institute, Cleveland, OH, USA

    Minzhong Yu

  2. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA

    Donnell Creel

  3. Center for Retinal Degenerations and Ophthalmic Genetic Diseases, Duke University School of Medicine, Duke Eye Center, Department of Ophthalmology, Durham, NC, USA

    Alessandro Iannaccone

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kheir, W.J. et al. (2019). Congenital Non-Degenerative Retinal Diseases. In: Yu, M., Creel, D., Iannaccone, A. (eds) Handbook of Clinical Electrophysiology of Vision. Springer, Cham. https://doi.org/10.1007/978-3-030-30417-1_4

Download citation

Publish with us

Policies and ethics

Search

Navigation